Login / Signup

Antibody responses to inactivated SARS-CoV-2 vaccine in peritoneal dialysis patients.

Ahmet MurtMehmet R AltiparmakDogukan OzbeySerkan F YalinSerap Sert YadigarRidvan KaraaliBekir KocazeybekNese SaltogluMeltem PekpakMuveddet R Ataman
Published in: Seminars in dialysis (2022)
Two doses of the inactivated vaccine generate adequate humoral immune response in PD patients without any serious adverse events.
Keyphrases
  • end stage renal disease
  • peritoneal dialysis
  • chronic kidney disease
  • immune response
  • sars cov
  • newly diagnosed
  • ejection fraction
  • inflammatory response